How to appeal a Humana asthma & severe allergies denial
42 CFR Part 422 Subpart M (Medicare Advantage) · 60-day window · 30-day decision
To appeal a Humana asthma & severe allergies denial, file an internal appeal within 60 days of the date on the denial letter through Humana's member or provider portal, under 42 CFR Part 422 Subpart M (Medicare Advantage). Humana returns standard decisions in 30 days; if it upholds the denial you can request an independent external review within 4 months.
The framework that applies to your appeal
Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).
Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.
What Humana's policy requires for asthma & severe allergies
Cited policy: Humana Pharmacy Policy — Allergen Immunotherapy (SCIT / SLIT / Palforzia)
Allergic rhinitis, allergic asthma, or Hymenoptera venom hypersensitivity with documented specific IgE. Inadequate control on pharmacotherapy or patient preference for disease-modifying therapy. Palforzia: peanut allergy ages 4-17 with confirmed IgE-mediated reaction.
How Humana denies asthma & severe allergies — and how to counter it
Where Humana pushes back: 1) Not medically necessary, use antihistamines; 2) Palforzia: avoid peanuts instead; 3) SLIT-tablets: try shots first.
Counter-arguments that hold up: AAAAI/ACAAI Allergen Immunotherapy Practice Parameter. EAACI AIT (Roberts Allergy 2018). GAP trial JACI 2018 — pediatric AR-to-asthma prevention. GRASS JAMA 2017. Durham NEJM 1999 sustained benefit. Palforzia: PALISADE NEJM 2018 — 67% tolerated 600mg vs 4% pbo; FDA Jan 31, 2020. Venom: AAAAI Stinging Insect Practice Parameter (Golden JACI 2017) — 95-98% efficacy, life-saving.
What Humana typically denies for asthma & severe allergies
Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For asthma & severe allergies, expect:
- MA plan step therapy on Part B drugs
- Skilled nursing facility days
- Prior auth on specialty drugs
- OON emergency reduction
Treatments most often denied in this category
These are the asthma & severe allergies treatments most often flagged for prior auth, step therapy, or medical necessity review:
- Xolair
- Dupixent (asthma)
- Nucala
- Fasenra
- Cinqair
- Tezspire
How to submit the appeal to Humana
- Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
- Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
- File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
- If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.
Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.
Frequently asked questions
How long do I have to appeal a Humana asthma & severe allergies denial?
Humana allows 60 days from the date on the denial letter to file an internal appeal. Standard decisions come back within 30 days; expedited decisions for urgent care typically within 72 hours.
What's the fastest way to submit a Humana appeal?
Members can submit through the Humana member portal at https://www.humana.com. Providers should use the provider portal at https://www.humana.com/provider. Faxed and mailed appeals are accepted but take longer.
What denials does Humana most often issue for asthma & severe allergies?
For asthma & severe allergies, Humana most often denies on: 1) Not medically necessary, use antihistamines; 2) Palforzia: avoid peanuts instead; 3) SLIT-tablets: try shots first. The strongest counters: AAAAI/ACAAI Allergen Immunotherapy Practice Parameter. EAACI AIT (Roberts Allergy 2018). GAP trial JACI 2018 — pediatric AR-to-asthma prevention. GRASS JAMA 2017. Durham NEJM 1999 sustained benefit. Palforzia: PALISADE NEJM 2018 — 67% tolerated 600mg vs 4% pbo; FDA Jan 31, 2020. Venom: AAAAI Stinging Insect Practice Parameter (Golden JACI 2017) — 95-98% efficacy, life-saving.
What if Humana denies the appeal too?
After an internal appeal denial you have the right to an external review by an independent reviewer (IRO) — request it within 4 months of the final internal denial.
Related appeal guides
Start your Asthma & severe allergies appeal
Upload your Humana denial letter — DenialHelp drafts a physician-ready appeal in five minutes, aligned to 42 CFR Part 422 Subpart M (Medicare Advantage).
Get started →Contact: hello@denialhelp.com